Log in
Login
Password
Remember
Lost password
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 

4-Traders Homepage  >  Shares  >  Nasdaq  >  Cyclacel Pharmaceuticals Inc    CYCC   US23254L3069

 SummaryQuotesChartsNewsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nasdaq
06/30/2015 07/01/2015 07/02/2015 07/06/2015 07/07/2015 Date
0.8(c) 0.785(c) 0.7799(c) 0.75(c) 0.7499(c) Last
216 428 138 055 67 418 232 515 269 347 Volume
+2.56% -1.88% -0.65% -3.83% -0.01% Change
More quotes
Financials ($)
More Financials
Company
Cyclacel Pharmaceuticals, Inc. is a biopharmaceutical company.It engages in developing oral therapies that target the various phases of cell cycle control for the treatment of cancer and other serious diseases.Its most advance product candidate, is the subject of SEAMLESS, a phase 3 trail being... 
More about the company
Latest news on CYCLACEL PHARMACEUTICALS I
07/03 CYCLACEL PHARMACEUTICALS : First Patient Dosed in IST of CDK Inhibitor Selicicli..
07/02 First Patient Dosed in IST of CDK Inhibitor Seliciclib in Cushing's Disease, ..
06/29 Cyclacel & ManRos Therapeutics Announce Licensing & Supply Agreement Regardin..
06/29 CYCLACEL PHARMACEUTICALS : & ManRos Therapeutics Announce Licensing & Supply Agr..
06/18 CYCLACEL PHARMACEUTICALS : to Present at 10th Annual JMP Securities Healthcare C..
06/17 Cyclacel Pharmaceuticals to Present at 10th Annual JMP Securities Healthcare ..
05/22 CYCLACEL PHARMACEUTICALS : Change in Directors or Principal Officers, Submission..
05/13 CYCLACEL PHARMACEUTICALS : Reports First Quarter 2015 Financial Results
More news
Sector news : Bio Therapeutic Drugs
07/07 INCYTE : and Vanderbilt University Medical Center Establish Multi-Year Oncology ..
07/07 GENMAB A/S : Announces European Regulatory Submission for Ofatumumab as Maintena..
07/07 SHANGHAI RAAS BLOOD PRODUCTS : Controller Kicks Off Holding Expansion
More sector news : Bio Therapeutic Drugs
News from SeekingAlpha
05/13 Cyclacel Pharma revenues up 25% in Q1
05/12 Cyclacel Pharmaceuticals' (CYCC) CEO Spiro Rombotis on Q1 2015 Results - Earn..
05/12 Cyclacel Pharmaceuticals beats by $0.06
04/15 Midday Gainers / Losers
03/25 Cyclacel Pharma ups revenues 55% in FY14


Comments 
Advertisement
Chart CYCLACEL PHARMACEUTICALS I
Duration : Period :
Cyclacel Pharmaceuticals I Technical Analysis Chart | CYCC | US23254L3069 | 4-Traders
Full-screen chart
Technical analysis trends
Short TermMid-TermLong Term
TrendsNeutralNeutralNeutral
Technical analysis
Income Statement Evolution
More Financials
EPS Revisions
More Estimates Revisions